Total Payments
$35,111
2024 Payments
$2,672
Companies
60
Transactions
1,010
Medicare Patients
10,236
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$20,926 (59.6%)
Other$12,450 (35.5%)
Travel$1,703 (4.9%)
Education$31.66 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,926 | 996 | 59.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,450 | 6 | 35.5% |
| Travel and Lodging | $1,703 | 4 | 4.9% |
| Education | $31.66 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $15,700 | 46 | $0 (2021) |
| Novo Nordisk Inc | $3,543 | 171 | $0 (2024) |
| ABBVIE INC. | $2,194 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,139 | 93 | $0 (2024) |
| Lilly USA, LLC | $1,323 | 73 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,186 | 51 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $972.44 | 47 | $0 (2024) |
| Allergan, Inc. | $753.43 | 40 | $0 (2021) |
| PFIZER INC. | $671.12 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $540.25 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,672 | 122 | AstraZeneca Pharmaceuticals LP ($462.55) |
| 2023 | $3,383 | 154 | AbbVie Inc. ($705.93) |
| 2022 | $3,131 | 159 | ABBVIE INC. ($673.55) |
| 2021 | $2,285 | 99 | Novo Nordisk Inc ($584.74) |
| 2020 | $1,971 | 108 | Novo Nordisk Inc ($417.45) |
| 2019 | $1,941 | 120 | Novo Nordisk Inc ($475.28) |
| 2018 | $7,352 | 114 | Janssen Pharmaceuticals, Inc ($5,562) |
| 2017 | $12,376 | 134 | Janssen Pharmaceuticals, Inc ($10,008) |
All Payment Transactions
1,010 individual payment records from CMS Open Payments — Page 40 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, OneTouch | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2017 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, BASAGLAR | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Diabetes | ||||||
| 04/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Diabetes | ||||||
| 03/31/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Diabetes | ||||||
| 03/28/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Endocrinology | ||||||
| 03/23/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Diabetes | ||||||
| 03/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/16/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 03/09/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $107.30 | General |
| Category: Diabetes | ||||||
| 03/07/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 03/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $735.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 02/28/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/17/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Respiratory | ||||||
| 02/15/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $116.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,482 | 5,961 | $982,925 | $498,632 |
| 2022 | 26 | 2,436 | 5,817 | $994,472 | $479,010 |
| 2021 | 27 | 2,592 | 6,096 | $955,625 | $480,462 |
| 2020 | 26 | 2,726 | 5,876 | $896,377 | $416,268 |
Total Patients
10,236
Total Services
23,750
Medicare Billing
$1.9M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 226 | 1,511 | $300,781 | $102,545 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 756 | $115,736 | $86,266 | 74.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 266 | 909 | $184,707 | $62,635 | 33.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 365 | $43,869 | $35,082 | 80.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 192 | 347 | $76,061 | $33,241 | 43.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 249 | 455 | $45,714 | $33,016 | 72.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 183 | 183 | $54,800 | $29,935 | 54.6% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 16 | 146 | $30,485 | $23,724 | 77.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 307 | $33,690 | $22,917 | 68.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $23,084 | $22,517 | 97.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 141 | 145 | $29,000 | $17,372 | 59.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 67 | $15,659 | $10,248 | 65.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 50 | 69 | $8,499 | $6,805 | 80.1% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 14 | 50 | $5,066 | $3,851 | 76.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 229 | $5,725 | $1,924 | 33.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 35 | $2,434 | $1,601 | 65.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 29 | 46 | $1,466 | $1,396 | 95.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 25 | $1,602 | $1,233 | 77.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $658.01 | $638.87 | 97.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $645.54 | $638.87 | 99.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 50 | $2,000 | $574.41 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 33 | $569.25 | $441.87 | 77.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 24 | 27 | $675.00 | $29.99 | 4.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 193 | 1,399 | $279,563 | $88,613 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 748 | $114,511 | $88,026 | 76.9% |
About Dr. Miguel Tirado, M.D
Dr. Miguel Tirado, M.D is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922072313.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miguel Tirado, M.D has received a total of $35,111 in payments from pharmaceutical and medical device companies, with $2,672 received in 2024. These payments were reported across 1,010 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($20,926).
As a Medicare-enrolled provider, Tirado has provided services to 10,236 Medicare beneficiaries, totaling 23,750 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Addiction Medicine
- Location Staten Island, NY
- Active Since 02/14/2006
- Last Updated 08/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922072313
Products in Payments
- XARELTO (Drug) $15,447
- VRAYLAR (Drug) $1,195
- FARXIGA (Drug) $1,109
- Ozempic (Drug) $1,108
- Kerendia (Drug) $972.44
- UBRELVY (Drug) $866.87
- Victoza (Drug) $809.15
- TRULICITY (Drug) $756.98
- TRELEGY ELLIPTA (Drug) $534.10
- XIFAXAN (Drug) $485.95
- QULIPTA (Drug) $473.99
- REXULTI (Drug) $415.38
- Rybelsus (Drug) $411.40
- SYMBICORT (Drug) $353.41
- BREZTRI (Drug) $349.99
- TRINTELLIX (Drug) $340.96
- Saxenda (Drug) $336.74
- JANUVIA (Drug) $326.30
- Tresiba (Drug) $307.23
- NURTEC ODT (Drug) $306.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Internal Medicine $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Internal Medicine $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Internal Medicine $61,903
Dr. Alan Dunton, M.d, M.D
Internal Medicine — Payments: $34,946
Internal Medicine $34,946
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178
Internal Medicine $29,178
Dr. Efat Azizi, M.d, M.D
Internal Medicine — Payments: $28,427
Internal Medicine $28,427